Login Register Cart 0
Generic placeholder image

Recent Patents on Biotechnology

Editor-in-Chief

ISSN (Print): 1872-2083
ISSN (Online): 2212-4012

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Lab-scale Preparation of Recombinant Human Insulin-like Growth Factor-1 in Escherichia coli and its Potential Safety on Normal Human Lung Cell Line

Author(s): Omnia A. Mohamed, Safia Samir*, Hanan Omar, Ekrami A. Hassan and Eman Abdelazeem

Volume 16, Issue 3, 2022

Published on: 25 May, 2022

Page: [266 - 280] Pages: 15

DOI: 10.2174/1872208316666220412105822

Price: $65

Abstract

Background: Insulin-like growth factor-1 (IGF-1) is structurally similar to insulin and acts as an endocrine hormone secreted by the liver.

Objective: Production of recombinant human IGF-1 (rhIGF-1) in Escherichia coli (E.coli) and evaluation of its proliferation stimulatory activity.

Methods: hIGF-1 gene cloned into pBSK (+) simple vector was transformed into TOP 10 chemically competent cells of E. coli. Polymerase chain reaction (PCR) was achieved using specific hIGF-1 gene primers to confirm the successful transformation. To express the rhIGF-1 in E. coli (Rosetta (DE3) pLysS); the hIGF-1 gene was cloned into the pET-15b expression vector and then the recombinant pET-15b/IGF-1 vector was transformed into a chemically prepared competent expression bacterial cells; Rosetta (DE3) pLysS. The rhIGF-1 was expressed as insoluble aggregates called inclusion bodies (IBs) using a 2 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) inducer. IBs were solubilized in a denatured form using 6 M guanidinium hydrochloride (GdmCl), followed by in vitro protein refolding using the rapid dilution method. The refolded hIGF-1 was purified using the HiTrap- ANX anion exchange column. Western blot and ELISA using rabbit polyvalent anti-hIGF- 1 were performed to confirm the protein antigenic identity. Cell proliferation activity of rhIGF-1 was testified on normal human lung cell line (WI-38).

Results: rhIGF-1 was purified from the HiTrap-ANX column at a concentration of 300 μg/ml. Western blot showed a single 7.6 kDa band obtained in the induced Rosetta (DE3) pLYsS. ELISA confirmed the molecular identity of the rhIGF-1 epitope, the concentration of purified rhIGF-1 obtained from the ELISA standard curve using rhIGF-1 reference protein as a standard was 300 μg/ml, and activity on WI-38 cells was 2604.17I U/mg.

Conclusion: Biologically active native rhIGF-1 protein was successfully expressed. Patents related to the preparation of IGF-1 were mentioned along the text.

Keywords: hIGF-1, recombinant expression, Escherichia coli, Western blot, ELISA, human lung cell line, proliferation assay.

« Previous Next »
Graphical Abstract

[1]
Rinderknecht E, Humbel RE. The amino acid sequence of human insulin-like growth factor I and its structural homolo-gy with proinsulin. J Biol Chem 1978; 253(8): 2769-76.
[http://dx.doi.org/10.1016/S0021-9258(17)40889-1] [PMID: 632300]
[2]
Hui M, Lia F, Tanga L, et al. Soluble expression of human insulin-like growth factor-1 with the assistance of SUMO fusion partner. J Chem Pharm Res 2014; 6(4): 1059-66.
[3]
Carroll PV, Umpleby M, Alexander EL, et al. Recombinant human insulin-like growth factor-I (rhIGF-I) therapy in adults with type 1 diabetes mellitus: Effects on IGFs, IGF-binding proteins, glucose levels and insulin treatment. Clin Endocrinol (Oxf) 1998; 49(6): 739-46.
[http://dx.doi.org/10.1046/j.1365-2265.1998.00600.x] [PMID: 10209561]
[4]
Clemmons DR. The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity. J Clin Invest 2004; 113(1): 25-7.
[http://dx.doi.org/10.1172/JCI20660] [PMID: 14702105]
[5]
Vinther TN, Norrman M, Ribel U, et al. Insulin analog with additional disulfide bond has increased stability and pre-served activity. Protein Sci 2013; 22(3): 296-305.
[http://dx.doi.org/10.1002/pro.2211] [PMID: 23281053]
[6]
Aguirre GA, De Ita JR, de la Garza RG, Castilla-Cortazar I. Insulin-like growth factor-1 deficiency and metabolic syn-drome. J Transl Med 2016; 14(1): 3.
[http://dx.doi.org/10.1186/s12967-015-0762-z] [PMID: 26733412]
[7]
Bentov H, Werner I. Insulin-like growth factor-1. In: Kastin A, Ed. Handbook of Biologically Active Peptides. 2nd ed. San Diego: Elsevier Press 2013; pp. 1627-32.
[8]
Colao A, Di Somma C, Cascella T, et al. Relationships between serum IGF1 levels, blood pressure, and glucose toler-ance: An observational, exploratory study in 404 subjects. Eur J Endocrinol 2008; 159(4): 389-97.
[http://dx.doi.org/10.1530/EJE-08-0201] [PMID: 18603571]
[9]
Jafari S, Babaeipour V, Seyedi HA, et al. Recombinant production of mecasermin in E. coli expression system. Res Pharm Sci 2014; 9(6): 453-61.
[PMID: 26339260]
[10]
Matsumoto R, Koga M, Kasayama S, et al. Factors correlated with serum insulin-like growth factor-I levels in health check-up subjects. Growth Horm IGF Res 2018; 40: 55-60.
[http://dx.doi.org/10.1016/j.ghir.2018.01.003]
[11]
Amrein B, Foser S, Lang K, et al. Conjugates of insulin-like growth factor-1 and poly(ethylene glycol) US Patent 0099699A1, 2015.
[12]
Glass DJ, Fornaro M. Stabilized insulin-like growth factor polypeptides. US Patent 0235538A1, 2014.
[13]
Fornaro M, Huber T, Zurini M. Stabilized insulin-like growth factor polypeptides. US Patent 10167329, 2019.
[14]
Wang Y, Wang X, Yu L, et al. Effects of Sr2+ on the preparation of Escherchia coli DH5α competent cells and plasmid transformation. PeerJ 2020; 8(1970): 1-20.
[http://dx.doi.org/10.7717/peerj.9480]
[15]
Froger A, Hall JE. Transformation of plasmid DNA into E. coli using the heat shock method. J Vis Exp 2007; (6): 253.
[http://dx.doi.org/10.3791/253] [PMID: 18997900]
[16]
Rahman MT, Uddin MS, Sultana R, Moue A, Setu M. Polymerase Chain Reaction (PCR): A short review. Anwer Khan Mod Med Coll J 2013; 4(1): 30-6.
[http://dx.doi.org/10.3329/akmmcj.v4i1.13682]
[17]
Wilson DA, Yen-Lieberman B, Schindler S, Asamoto K, Schold JD, Procop GW. Should varicella-zoster virus culture be eliminated? A comparison of direct immunofluorescence antigen detection, culture, and PCR, with a historical review. J Clin Microbiol 2012; 50(12): 4120-2.
[http://dx.doi.org/10.1128/JCM.06753-11] [PMID: 23035203]
[18]
Jie J, Chu X, Li D, Luo Z. A set of shuttle plasmids for gene expression in Acinetobacter baumannii. PLoS One 2021; 16(2): e0246918.
[http://dx.doi.org/10.1371/journal.pone.0246918] [PMID: 33566854]
[19]
Bartlett A, O’Malley RC, Huang SC, et al. Mapping genome-wide transcription-factor binding sites using DAP-seq. Nat Protoc 2017; 12(8): 1659-72.
[http://dx.doi.org/10.1038/nprot.2017.055] [PMID: 28726847]
[20]
Lodish HDJ, Berk A, Zipursky SL, Matsudaira P, Baltimore D. DNA cloning with plasmid vectors. In: Molecular Cell Biology. 4th ed. New York: W. H. Freeman 2000.
[21]
Liao MJ, Zhu MY, Zheng X, Zhang ZH, Zhang AJ. cDNA cloning of growth hormone from giant panda (Ailuropoda melanoleuca) and its expression in Escherichia coli. Comp Biochem Physiol B Biochem Mol Biol 2003; 135(1): 109-16.
[http://dx.doi.org/10.1016/S1096-4959(03)00056-3] [PMID: 12781978]
[22]
Das A, Verma A, Mukherjee KJ. Synthesis of dopamine in E. coli using plasmid-based expression system and its marked effect on host growth profiles. Prep Biochem Biotechnol 2017; 47(8): 754-60.
[http://dx.doi.org/10.1080/10826068.2017.1320291] [PMID: 28430025]
[23]
Burnette WN. “Western blotting”: Electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981; 112(2): 195-203.
[http://dx.doi.org/10.1016/0003-2697(81)90281-5] [PMID: 6266278]
[24]
Palmer I, Wingfield P T. Preparation and extraction of insoluble (Inclusion-body) proteins from Escherichia coli Curr Protoc Protein Sci 2012. 1(Suppl.70).
[http://dx.doi.org/10.1002/0471140864.ps0603s70]
[25]
Kaur J, Singh A, Panda AK, Lal R. Protocol for in-vitro purification and refolding of hexachlorocyclohexane degrading enzyme haloalkane dehalogenase LinB from inclusion bodies. Enzyme Microb Technol 2021; 146: 109760.
[http://dx.doi.org/10.1016/j.enzmictec.2021.109760]
[26]
Singh A, Upadhyay V, Upadhyay AK, Singh SM, Panda AK. Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process. Microb Cell Fact 2015; 14(1): 41.
[http://dx.doi.org/10.1186/s12934-015-0222-8] [PMID: 25889252]
[27]
Careen Khachatoorian A, Ramirez AR, Hernandez F, Serna R, Kwok EY. Overexpressed Arabidopsis Annexin4 accu-mulates in inclusion bodylike structures. Acta Histochem 2015; 117(3): 279-87.
[http://dx.doi.org/10.1016/j.acthis.2015.03.005] [PMID: 25818562]
[28]
Singh SM, Panda AK. Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng 2005; 99(4): 303-10.
[http://dx.doi.org/10.1263/jbb.99.303] [PMID: 16233795]
[29]
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the princi-ple of protein-dye binding. Anal Biochem 1976; 72(72): 248-54.
[http://dx.doi.org/10.1016/0003-2697(76)90527-3] [PMID: 942051]
[30]
Lange C, Rudolph R. Production of recombinant proteins for therapy, diagnostics, and industrial research by in vitro folding. Protein Fold Handb 2008; 3: 1245-80.
[31]
El-Dabaa E. Biotechnology in action; R&D in interferon alpha production. Application of biotechnology in industery and medicine, future prospects in egypt (GUC event). German University in Cairo, Egypt 26-27 March 2016; p. 2016.
[32]
Weiss T, Joachim W. Handbook of Ion Chromatography.Germany, Weinheim: Wiley-VCH Verlag GmbH & Co KGaA. 2005; pp. 1-9.
[33]
Okasha H, Nasr SM, Samir S. Recombinant expression of Cec-B peptide in Escherichia coli with a significant anti-cancer effect on hepatocellular carcinoma. Curr Pharm Biotechnol 2021; 22(9): 1235-45.
[http://dx.doi.org/10.2174/1389201022666210104121709] [PMID: 33397234]
[34]
Adan A, Kiraz Y, Baran Y. Cell proliferation and cytotoxicity assays. Curr Pharm Biotechnol 2016; 17(14): 1213-21.
[http://dx.doi.org/10.2174/1389201017666160808160513] [PMID: 27604355]
[35]
Fiorentino FP, Bagella L, Marchesi I. A new parameter of growth inhibition for cell proliferation assays. J Cell Physiol 2018; 233(5): 4106-15.
[http://dx.doi.org/10.1002/jcp.26208]
[36]
Huat TJ, Khan AA, Pati S, Mustafa Z, Abdullah JM, Jaafar H. IGF-1 enhances cell proliferation and survival during early differentiation of mesenchymal stem cells to neural progenitor-like cells. BMC Neurosci 2014; 15(1): 91.
[http://dx.doi.org/10.1186/1471-2202-15-91] [PMID: 25047045]
[37]
Senthilraja P, Kathiresan K. In vitro cytotoxicity MTT assay in vero, HepG2 and MCF-7 cell lines study of marine yeast. J Appl Pharm Sci 2015; 5(3): 80-4.
[http://dx.doi.org/10.7324/JAPS.2015.50313]
[38]
Elnagar MM, et al. Synthesis, characterization, and evaluation of biological activities of new 4′-substituted ruthenium (II) terpyridine complexes: Prospective anti-inflammatory properties. Appl Organomet Chem 2020.
[http://dx.doi.org/10.1002/aoc.6024]
[39]
Bailes J, Soloviev M. Insulin-like growth factor-1 (IGF-1) and its monitoring in medical diagnostic and in sports. Biomolecules 2021; 11(2): 1-15.
[http://dx.doi.org/10.3390/biom11020217] [PMID: 33557137]
[40]
Okasha H, Samir S, Nasr SM. Purified recombinant human Chromogranin A N46 peptide with remarkable anticancer effect on human colon cancer cells. Bioorg Chem 2021; 115(June): 105266.
[http://dx.doi.org/10.1016/j.bioorg.2021.105266] [PMID: 34449322]
[41]
Kim YS, Lee HJ, Han MH, Yoon NK, Kim YC, Ahn J. Effective production of human growth factors in Escherichia coli by fusing with small protein 6HFh8. Microb Cell Fact 2021; 20(1): 9.
[http://dx.doi.org/10.1186/s12934-020-01502-1] [PMID: 33413407]
[42]
Zieliński M, Romanik-Chruścielewska A, Mikiewicz D, et al. Expression and purification of recombinant human insulin from E. coli 20 strain Protein Expr Purif 2019; 157: 63-9.
[http://dx.doi.org/10.1016/j.pep.2019.02.002] [PMID: 30735706]
[43]
Lipinszki Z, Vernyik V, Farago N, et al. Enhancing the Translational Capacity of E. coli by Resolving the Codon Bias. ACS Synth Biol 2018; 7(11): 2656-64.
[http://dx.doi.org/10.1021/acssynbio.8b00332] [PMID: 30351909]
[44]
Grönberg A. Ion exchange chromatography. Biopharm Process 2018; 379-99.
[http://dx.doi.org/10.1016/B978-0-08-100623-8.00018-9]
[45]
Pergande MR, Cologna SM. Isoelectric point separations of peptides and proteins. Proteomes 2017; 5(1): E4.
[http://dx.doi.org/10.3390/proteomes5010004] [PMID: 28248255]
[46]
Merkus HG, Meesters GMH, Oostra W. Particles and nanoparticles in pharmaceutical products design, manufacturing, behavior and performance. AAPS Advances in the Pharmaceutical Sciences Series 2018.
[47]
HiTrapTM DEAE FF. 1. GE Healthc bio-sciences AB 2018; 1-28.Available from: www.gelifesciences.com/hitrap
[48]
Zhang R, Ruan D, Zhang C. Effects of TGF-β1 and IGF-1 on proliferation of human nucleus pulposus cells in medium with different serum concentrations. J Orthop Surg Res 2006; 1(1): 9.
[http://dx.doi.org/10.1186/1749-799X-1-9] [PMID: 17150129]
[49]
Aboutalebi F, Lachinani L, Khazaei Y, et al. An efficient method for bacterial production and activity assessment of recombinant human insulin like growth factor 1. Mol Biol Rep 2018; 45(6): 1957-66.
[http://dx.doi.org/10.1007/s11033-018-4348-8] [PMID: 30203241]

Rights & Permissions Print Cite
Article Metrics
41
1
© 2024 Bentham Science Publishers | Privacy Policy